These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3439855)

  • 1. Affino-immunoelectrophoresis of haptoglobin with wheat germ agglutinin. Diagnostic significance in ovarian carcinoma.
    Katnik I; Gerber J; Dobryszycka W
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):547-52. PubMed ID: 3439855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the reaction of haptoglobin with concanavalin A in affino-immunoelectrophoresis.
    Katnik I
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):267-75. PubMed ID: 3446085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microheterogeneity of alpha 1-acid glycoprotein in the sera of patients with cancer or inflammatory states of the ovaries.
    Katnik I; Gerber J; Dobryszycka W
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):1-6. PubMed ID: 3233059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical blood studies in patients with ovarian carcinoma treated with C-283. 3. Immunoelectrophoresis of serum proteins.
    Dobryszycka W; Gerber J; Jabloński K; Bec I
    Arch Immunol Ther Exp (Warsz); 1972; 20(3):367-73. PubMed ID: 4115628
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fermented wheat germ extract in the supportive therapy of colorectal cancer].
    Farkas E
    Orv Hetil; 2005 Sep; 146(37):1925-31. PubMed ID: 16255377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic factor for evaluation of the effectiveness of the therapy in ovarian carcinoma.
    Dobryszycka W; Waszkiewicz L; Kuriata E; Peisert E; Gerber J; Ujec M
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):623-9. PubMed ID: 3455651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum haptoglobin, CA 125 and interleukin 6 levels in malignant and non-malignant tumors of the ovary.
    Dobryszycka W; Katnik-Prastowska I; Gerber J; Lemańska K; Utko K; Rozdolski K
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):229-36. PubMed ID: 10483871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of the sequence of therapeutic procedures in the combined treatment of ovarian cancer patients (based on the criterion of the onset and duration or remission)].
    Zadontseva NS
    Vopr Onkol; 1985; 31(12):57-61. PubMed ID: 4082509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approaches to diagnosis and treatment of ovarian germ cell malignancies.
    Fishman DA; Schwartz PE
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):98-104. PubMed ID: 8180359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haptoglobin concentration in serum and other body fluids measured by comparison of its reactivity with hemoglobin and concanavalin A.
    Katnik I; Jadach J
    Arch Immunol Ther Exp (Warsz); 1996; 44(1):45-50. PubMed ID: 8874769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical studies of cancer patients treated with acridine derivative (C-283). IV. Changes in the levels of serum haptoglobin and sialic acid.
    Dobryszycka W; Osada J; Gerber J; Jablonski K
    Arch Immunol Ther Exp (Warsz); 1973; 21(2):271-9. PubMed ID: 4790848
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of ovarian germ cell tumours.
    Newlands ES
    Forum (Genova); 2000; 10(4):368-80. PubMed ID: 11535986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haptoglobin types in ovarian tumors.
    Dobryszycka W; Warwas M
    Neoplasma; 1983; 30(2):169-72. PubMed ID: 6843722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum haptoglobin in patients with ovarian malignancies.
    Mueller WK; Handschumacher R; Wade ME
    Obstet Gynecol; 1971 Sep; 38(3):427-35. PubMed ID: 4999312
    [No Abstract]   [Full Text] [Related]  

  • 18. Separation and identification of serum gamma-glutamyl transpeptidase isoenzymes by wheat germ agglutinin affinity electrophoresis: a basic analysis and its clinical application to various liver diseases.
    Okuyama K
    Keio J Med; 1993 Dec; 42(4):149-56. PubMed ID: 7907377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of the O6-methylguanine-DNA methyltransferase and glutathione S-transferase activity in the sera of patients with malignant and benign ovarian tumors.
    Akçay T; Dinçer Y; Alademir Z; Aydinli K; Arvas M; Demirkiran F; Kösebay D
    Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):108-13. PubMed ID: 15734094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.